BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7970710)

  • 21. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
    Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
    Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mechanism of discrimination between cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors.
    Sauvé S; Naud JF; Lavigne P
    J Mol Biol; 2007 Jan; 365(4):1163-75. PubMed ID: 17109882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis.
    Hurlin PJ; Foley KP; Ayer DE; Eisenman RN; Hanahan D; Arbeit JM
    Oncogene; 1995 Dec; 11(12):2487-501. PubMed ID: 8545105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Jun inhibits myogenic differentiation.
    Su HY; Bos TJ; Monteclaro FS; Vogt PK
    Oncogene; 1991 Oct; 6(10):1759-66. PubMed ID: 1656361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular basis of skeletal muscle differentiation.
    Dias P; Dilling M; Houghton P
    Semin Diagn Pathol; 1994 Feb; 11(1):3-14. PubMed ID: 8202645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myogenin expression is necessary for commitment to differentiation and is closely related to src tyrosine kinase activity in quail myoblasts transformed with Rous sarcoma virus.
    Hirayama E; Isobe A; Okamoto H; Nishioka M; Kim J
    Eur J Cell Biol; 1997 Feb; 72(2):133-41. PubMed ID: 9157009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA binding by N- and L-Myc proteins.
    Ma A; Moroy T; Collum R; Weintraub H; Alt FW; Blackwell TK
    Oncogene; 1993 Apr; 8(4):1093-8. PubMed ID: 8455937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transcription activation domains of v-Myc and VP16 interact with common factors required for cellular transformation and proliferation.
    Min S; Crider-Miller SJ; Taparowsky EJ
    Cell Growth Differ; 1994 Jun; 5(6):563-73. PubMed ID: 8086335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells.
    Cogliati T; Dunn BK; Bar-Ner M; Cultraro CM; Segal S
    Oncogene; 1993 May; 8(5):1263-8. PubMed ID: 8479748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
    Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S
    Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells.
    Cornelison DD; Wold BJ
    Dev Biol; 1997 Nov; 191(2):270-83. PubMed ID: 9398440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-MYC: evidence for multiple regulatory functions.
    Penn LJ; Laufer EM; Land H
    Semin Cancer Biol; 1990 Feb; 1(1):69-80. PubMed ID: 2133113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. v-jun oncogene prevents terminal differentiation and suppresses muscle-specific gene expression in ASV-17-infected muscle cells.
    Grossi M; Calconi A; Tatò F
    Oncogene; 1991 Oct; 6(10):1767-73. PubMed ID: 1923502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular biology of myogenic regulatory factors.
    Funk WD; Ouellette M; Wright WE
    Mol Biol Med; 1991 Apr; 8(2):185-95. PubMed ID: 1806761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation.
    Sorrentino V; Pepperkok R; Davis RL; Ansorge W; Philipson L
    Nature; 1990 Jun; 345(6278):813-5. PubMed ID: 2359457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leucine limitation regulates myf5 and myoD expression and inhibits myoblast differentiation.
    Averous J; Gabillard JC; Seiliez I; Dardevet D
    Exp Cell Res; 2012 Feb; 318(3):217-27. PubMed ID: 22079119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation.
    Miner JH; Wold BJ
    Mol Cell Biol; 1991 May; 11(5):2842-51. PubMed ID: 1850105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of vertebrate muscle differentiation by thyroid hormone: the role of the myoD gene family.
    Muscat GE; Downes M; Dowhan DH
    Bioessays; 1995 Mar; 17(3):211-8. PubMed ID: 7748175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line.
    Shapiro DN; Houghton PJ; Hazelton BJ; Germain GS; Murti KG; Rahman A; Houghton JA
    Cancer Res; 1990 Sep; 50(18):6002-9. PubMed ID: 2203524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The myc gene family proteins and their role in transformation and differentiation.
    Ingvarsson S
    Semin Cancer Biol; 1990 Dec; 1(6):359-69. PubMed ID: 2103508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.